← SynDRA
icatibant
SynDRA canonical compound SYN0041280 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | BDKRB2 |
|---|
| Mechanism of action | bradykinin receptor antagonist |
|---|
| Indication | angioedema |
|---|
| Disease area | cardiology |
|---|
All known targets
- BDKRB2
- BDKRB1
- Bdkrb1
- Bdkrb2
Mechanisms of action (all sources)
- BDKRB2 ANTAGONIST
- Bradykinin B2 receptor antagonist
- bradykinin receptor antagonist
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Bradykinin B2 Receptor Antagonists
- Bradykinin Receptor Antagonists
- Complement Inactivating Agents
- Immunologic Factors
- Immunosuppressive Agents
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- B06A · OTHER HEMATOLOGICAL AGENTS
Cross-references
Synonyms
- icatibant accord
- WIN 65365
- firazyr
- icatibant acetate
- Icatibanto
- Firazyr
- Icatibant [INN]
- Hoe-140
- HOE140
- JE049
- WIN-65365
- D-Arg(Hyp(3)-Thi(5)-D-Tic(7)-Oic(8))BK
- 7PG89G35Q7
- icatibanto
- JE 049
- icatibantum
- RefChem:57034
- B06AC02
- DTXCID901331902
- D-Arg(Hyp(3)-Thi(5)-L-Tic(7)-Oic(8))BK
- CHEBI:68556
- C59H89N19O13S
- Icatibant [INN:BAN]
- UNII-7PG89G35Q7
- Icatibant Acetate
- Icatibant (Standard)
- Icatibant HOE 140
- ICATIBANT [MI]
- ICATIBANT [VANDF]
- HOE-140 (Icatibant)
- ICATIBANT [WHO-DD]
- ICATIBANT [EMA EPAR]
- HOE 140 TFA
- SCHEMBL21495177
- SCHEMBL21495179
- GLXC-22881
- BDBM50403371
- BDBM50406750
Look up icatibant in the interactive SynDRA portal →